Gene polymorphisms in bladder cancer

Urologic Oncology
Maria FranekovaDusan Dobrota

Abstract

In Europe, cancer of the bladder is the fourth most common cancer among men, accounting for 7% of total cancers. In the USA, bladder cancer is the fifth most common cancer in men and seventh in women. This disease is three times more common in men than in women. Several risk factors, such as cigarette smoking and occupational chemical exposure, contribute to bladder cancer development. The balance between activation and detoxification of carcinogens affects the amount of DNA damage that accumulates in cells. The entire process leading to DNA damage and subsequent repair of the damage involves a host of enzymes, many of which are polymorphic. Polymorphisms in metabolic enzyme genes and repair genes may cause alterations in protein product functions that can finally lead to genomic instability and carcinogenesis. In this article, we review the polymorphisms in a number of genes that have been found to be the modulators of bladder cancer risk. Improved understanding of the molecular biology of urothelial malignancies is helping to more clearly define the role of new prognostic indices and multidisciplinary treatment for this disease.

References

Nov 13, 1996·JAMA : the Journal of the American Medical Association·C B AmbrosoneP G Shields
Nov 5, 1997·Biochemical and Biophysical Research Communications·R B RaftogianisR M Weinshilboum
Apr 17, 1998·Cancer Detection and Prevention·S Z Abdel-RahmanW W Au
Oct 8, 1999·International Journal of Urology : Official Journal of the Japanese Urological Association·H InatomiT Matsumoto
Mar 29, 2000·BJU International·C N Sternberg, F Calabrò
Jun 14, 2000·Clinical Genetics·E SchnakenbergW Schloot
Feb 15, 2001·Cytogenetics and Cell Genetics·E SchnakenbergW Schloot
Jul 19, 2001·Journal of the National Cancer Institute·A A Adjei
Sep 6, 2001·Mutation Research·R C StrangeA A Fryer
Jan 17, 2002·Mayo Clinic Proceedings·Orhun H KantarciBrian G Weinshenker
Feb 22, 2002·International Journal of Cancer. Journal International Du Cancer·Lizhong WangTetsuro Kato
Mar 13, 2002·Cancer Letters·Nikolaos SoulitzisDemetrios A Spandidos
Jun 12, 2002·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Matthew B SchabathXifeng Wu
Sep 27, 2002·Human Mutation·Mikael OscarsonMagnus Ingelman-Sundberg
Jan 25, 2003·Journal of Biochemistry and Molecular Biology·Daehee Kang
Feb 5, 2003·Cancer Letters·Tasha R SmithJennifer J Hu
Feb 18, 2003·Fundamental & Clinical Pharmacology·A K Daly
Apr 16, 2003·Mutation Research·Seun-Ja ParkXifeng Wu
May 28, 2003·Cancer Letters·Hiromasa TsukinoTakahiko Katoh
Aug 5, 2003·Carcinogenesis·Victoria K CortessisMimi C Yu
Sep 12, 2003·DNA Repair·Keith W Caldecott
Oct 17, 2003·Current Drug Targets. Inflammation and Allergy·Bharat B AggarwalAlok C Bharti
Dec 23, 2003·Carcinogenesis·Somali SanyalKari Hemminki
Jan 28, 2004·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Julia A KnightHilmi Ozcelik
Mar 5, 2004·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·David A FishbainR Steele Rosomoff
Mar 23, 2004·Annals of the New York Academy of Sciences·Imed MabroukAli Gargouri
Apr 2, 2004·Archives of Toxicology·Daya Shankar Lal SrivastavaRama Devi Mittal
May 4, 2004·International Journal of Cancer. Journal International Du Cancer·Rayjean J HungStefano Porru
Aug 18, 2004·Cancer Letters·Nicklas R JacobsenUlla Vogel
Sep 18, 2004·Cancer Research·David M BermanXifeng Wu
Sep 24, 2004·Cancer Genetics and Cytogenetics·Hong-Ping YuShun-Qing Xu

❮ Previous
Next ❯

Citations

Oct 5, 2013·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Xiao-Dong MengJun Xiao
Feb 26, 2014·Clinics and Research in Hepatology and Gastroenterology·Ariela F FundiaIrma Slavutsky
Oct 7, 2014·Irish Journal of Medical Science·G G CeylanA Gözalan
Apr 16, 2013·The Science of the Total Environment·Deborah W KnappAngus S Murphy
Mar 30, 2012·Molecular Carcinogenesis·Hatice TigliNur Buyru
Nov 8, 2014·Asia-Pacific Journal of Clinical Oncology·Md Bayejid HosenYearul Kabir
Oct 13, 2009·International Journal of Cancer. Journal International Du Cancer·Helena NordTeresita Díaz de Ståhl
Jan 10, 2016·Annals of Clinical Biochemistry·Esra LalogluFatih Akcay
Jan 14, 2018·BMC Research Notes·Marcelo Soares da Mota E SilvaFernanda Lattario Ribeiro
Apr 23, 2019·Journal of Veterinary Internal Medicine·Katherine R LuethckeLauren A Trepanier
Mar 25, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Md Bayejid HosenYearul Kabir
Jul 19, 2012·Oncology Letters·Gang WangGuangdi Chen
May 21, 2015·American Society of Clinical Oncology Educational Book·Deborah W KnappElaine Ostrander

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bladder Carcinoma In Situ

Bladder Carcinoma In Situ is a superficial bladder cancer that occurs on the surface layer of the bladder. Discover the latest research on this precancerous condition in this feed.

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.